Substance P activates responses correlated with tumour growth in human glioma cell lines bearing tachykinin NK1 receptors.
about
Biological and Pharmacological Aspects of the NK1-ReceptorThe substance P/NK-1 receptor system: NK-1 receptor antagonists as anti-cancer drugs.Anti-HIV-1 activity of the neurokinin-1 receptor antagonist aprepitant and synergistic interactions with other antiretrovirals.Neurokinin-1 receptor directly mediates glioma cell migration by up-regulation of matrix metalloproteinase-2 (MMP-2) and membrane type 1-matrix metalloproteinase (MT1-MMP).Anti-tumour activity of tachykinin NK1 receptor antagonists on human glioma U373 MG xenograft.Effect of a neurokinin-1 receptor antagonist in a rat model of colitis-associated colon cancerInvolvement of substance P and the NK-1 receptor in pancreatic cancer.Targeting tachykinin receptors in neuroblastoma.Neurokinin-1 receptor antagonists: a comprehensive patent survey.NK-1 receptor antagonists as antitumor drugs: a survey of the literature from 2000 to 2011.β-Arrestin 1 has an essential role in neurokinin-1 receptor-mediated glioblastoma cell proliferation and G2/M phase transition.Molecular imaging probes derived from natural peptides.The NK-1 receptor is expressed in human melanoma and is involved in the antitumor action of the NK-1 receptor antagonist aprepitant on melanoma cell lines.Immunolocalization of full-length NK1 tachykinin receptors in human tumors.The NK-1 Receptor Antagonist L-732,138 Induces Apoptosis and Counteracts Substance P-Related Mitogenesis in Human Melanoma Cell Lines.Walker 256 tumour cells increase substance P immunoreactivity locally and modify the properties of the blood-brain barrier during extravasation and brain invasion.Neuroendocrine Factors and Head and Neck Squamous Cell Carcinoma: An Affair to Remember.The role of neurokinin-1 receptor in the microenvironment of inflammation and cancer
P2860
Q26784074-3CA17E27-328B-4A08-B72A-BC6867E25BCCQ34475975-F8D20324-315E-4DEB-9865-EC00607AA5B7Q36043712-10437354-6525-44E0-A8DD-32EBE8040CBFQ36508615-5835E2EF-E6C7-4D91-A307-C458376044F4Q36621139-47F996B4-623C-49E9-98E9-DF821B142E14Q37070499-E28865DE-2A28-4E34-AA77-FDE82271F8BCQ37617971-D0FF545D-2B1D-42EC-8C8E-874742E628A1Q37702248-40F9B5D8-4C2E-4B8E-BCD8-B99194D0E983Q37763716-06C31834-8173-45F2-982E-0B110A2BDEA0Q38018635-A810625E-7A66-4B5A-9C6B-CAAF23942A92Q38710607-E5E8F9FD-B9EC-41B3-85AD-D93787E02941Q38748846-62D8BDF6-4088-438D-B395-0913D53F25F5Q39705448-4B0B1906-A068-40A6-988C-3FC55EF03F98Q40285095-DC81B6F3-63F5-4071-AABF-1B2172B30EF1Q42875830-ED414EED-AA38-4C3B-861C-808CE0355DE9Q43628974-D1414B42-F9D6-4241-98D9-89868DACAD8DQ55020898-A962B3D4-3F67-4078-853D-EC460D8B140CQ58914868-7AE640FF-3FD5-458C-A18F-3614812D4824
P2860
Substance P activates responses correlated with tumour growth in human glioma cell lines bearing tachykinin NK1 receptors.
description
1999 nî lūn-bûn
@nan
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
1999年论文
@zh
1999年论文
@zh-cn
name
Substance P activates response ...... ring tachykinin NK1 receptors.
@en
type
label
Substance P activates response ...... ring tachykinin NK1 receptors.
@en
prefLabel
Substance P activates response ...... ring tachykinin NK1 receptors.
@en
P2093
P2860
P356
P1476
Substance P activates response ...... ring tachykinin NK1 receptors.
@en
P2093
P2860
P2888
P304
P356
10.1038/SJ.BJC.6690039
P407
P577
1999-01-01T00:00:00Z